Estrogens
An estrogen test measures the level of the most important estrogen hormones ( estradiol, estriol, and estrone) in a blood or urine sample.
- Estradiol is the most commonly measured type of estrogen for nonpregnant women. The amount of estradiol in a woman's blood varies throughout her menstrual cycle. After menopause, estradiol production drops to a very low but constant level.
- Estriol levels usually are only measured during pregnancy. Estriol is produced in large amounts by the placenta, the tissue that links the fetus to the mother. It can be detected as early as the 9th week of pregnancy, and its levels increase until delivery. Estriol can also be measured in urine.
- Estrone may be measured in women who have gone through menopause to determine their estrogen levels. It also may be measured in men or women who might have cancer of the ovaries, testicles, or adrenal glands.
Both men and women produce estrogen hormones. Estrogens are responsible for female sexual development and function, such as breast development and the menstrual cycle. In women, estrogens are produced mainly in the ovaries and in the placenta during pregnancy. Small amounts are also produced by the adrenal glands. In men, small amounts of estrogens are produced by the adrenal glands and testicles. Small amounts of estrone are made throughout the body in most tissues, especially fat and muscle. This is the major source of estrogen in women who have gone through menopause.
Why It Is Done
A test for estrogen is done to:
- Help detect fetal birth defects (especially Down syndrome) during pregnancy. When the test for estriol is combined with alpha-fetoprotein (AFP) and human chorionic gonadotropin (hCG), it is called a triple screen test. When the amount of a hormone called inhibin A is also measured along with estriol, AFP, and hCG, the test is called a quad marker screen. Other blood tests and fetal ultrasound may be done as well.
- Evaluate estrogen-producing tumors of the ovaries in girls before menstruation starts and in women after menopause.
- Explain abnormal sexual characteristics in men, such as enlarged breasts (gynecomastia). This test can also help detect the presence of estrogen-producing tumors growing in the testicles.
- Monitor therapy with fertility medicines.
How To Prepare
No special preparation is required before having an estrogen test.
Tell your health professional if you:
- Are menstruating. Note where you are in your menstrual cycle.
- Are using birth control pills, patches, or rings and other forms of hormonal birth control.
- Are or might be pregnant.
Talk to your health professional about any concerns you
have regarding the need for the test, its risks, how it will be done, or what
the results will indicate. To help you understand the importance of this test,
fill out the
medical test information form
(What is a PDF document?).
WebMD Medical Reference from Healthwise
VIVELLE-DOT (estradiol transdermal system) IS AVAILABLE BY PRESCRIPTION ONLY.
INDICATION
Vivelle-Dot is used after menopause to: reduce moderate to severe hot flashes; treat moderate to severe dryness, itching and burning in or around the vagina; help reduce your chances of getting osteoporosis (thin weak bones); and treat certain conditions in which a young woman's ovaries do not produce enough estrogens naturally. Vivelle-Dot 0.025 mg/day is only used to prevent osteoporosis from menopause. If you use Vivelle-Dot only to treat your dryness, itching, and burning in and around your vagina or if you use Vivelle-Dot only to prevent osteoporosis from menopause, talk with your healthcare professional about whether a different treatment or medicine without estrogens might be better for you.
IMPORTANT SAFETY INFORMATION
Estrogens increase the chances of getting cancer of the uterus (womb). Report any unusual vaginal bleeding right away while you are taking estrogens. Vaginal bleeding after menopause may be a warning sign of cancer of the uterus (womb).
Do not use estrogens with or without progestins to prevent heart disease, heart attacks, or strokes. Using estrogens with or without progestins may increase your chances of getting heart attacks, strokes, breast cancer, and blood clots. Using estrogens with progestins may increase your risk of dementia (decline in memory and thinking skills).
Vivelle-Dot should not be used if you have unusual vaginal bleeding; currently have or have had certain cancers, including cancer of the breast or uterus; had a stroke or heart attack in the recent past (for example, in the past year); currently have or have had blood clots; currently have or have had liver problems; or think you may be, or know that you are, pregnant.
The most common side effects that may occur with Vivelle-Dot are headache, breast tenderness, and back pain.
You and your healthcare professional should talk regularly about whether you still need treatment with Vivelle-Dot.
You are encouraged to report negative side effects of prescription drugs to the FDA. Visit www.fda.gov/medwatch or call 1-800-FDA-1088.
Please see Full Prescribing Information for Vivelle-Dot.

